Log In
Print this Print this

Glubes, mitiglinide/voglibose (KMV-0207)

  Manage Alerts
Collapse Summary General Information
Company Kissei Pharmaceutical Co. Ltd.
DescriptionCombination of mitiglinide-voglibose
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsImprovement of postprandial plasma glucose transition in patients with Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today